These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 201569)

  • 21. Persistent infection of mouse cells with Sindbis virus: role of virulence of strains, auto-interfering particles and interferon.
    Inglot AD; Albin M; Chudzio T
    J Gen Virol; 1973 Jul; 20(1):105-10. PubMed ID: 4356681
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon production and infection caused by vesicular stomatitis virus in radiation chimeras.
    Mentkevich LM; Orlova TG; Shcheglovitova ON; Solovyov VD
    Acta Virol; 1973 Mar; 17(2):159-62. PubMed ID: 4144281
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
    tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
    J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of replication of vesicular stomatitis virus in human lymphocyte cultures treated with heterologous anti-lymphocyte serum.
    Edelman R; Wheelock EF
    Lancet; 1968 Apr; 1(7546):771-5. PubMed ID: 4171127
    [No Abstract]   [Full Text] [Related]  

  • 25. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged infection of L cells with vesicular stomatitis virus. Defective interfering forms and temperature-sensitive mutants as factors in the infection.
    Ramseur JM; Friedman RM
    Virology; 1978 Mar; 85(1):253-61. PubMed ID: 206006
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in the response of normal and transformed BHK21 cells to dual virus infection. Conditions affecting synergism between vesicular stomatitis virus and newcastle disease virus.
    Kisch AL; Gould I
    Virology; 1973 Nov; 56(1):1-11. PubMed ID: 4355526
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of "Aquasol A", vitamin A, and "Tween 80" on vesicular stomatitis virus plaque formation and on interferon action.
    Blalock JE; Gifford GE
    Arch Gesamte Virusforsch; 1974; 45(1-2):161-4. PubMed ID: 4369949
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of mycoplasma on interferon production and interferon assay in cell cultures.
    Armstrong D; Paucker K
    J Bacteriol; 1966 Jul; 92(1):97-101. PubMed ID: 4287405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon induces an antiviral state in ganglioside-deficient transformed mouse fibroblasts.
    Schiffmann D; Koschel K
    Med Microbiol Immunol; 1981; 169(4):281-9. PubMed ID: 6168900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat interferons. III. Antiviral activity and effect of "priming" on interferon production in homologous and heterologous cell lines.
    Lobodzińska M; Biernacka I; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(2):225-31. PubMed ID: 238487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. I. Rescue in cell cultures from different species.
    Thacore HR; Youngner JS
    Virology; 1973 Dec; 56(2):505-11. PubMed ID: 4357053
    [No Abstract]   [Full Text] [Related]  

  • 33. Altered cellular responses to interferon induction by poly I-poly C: priming and hyporesponsiveness in cells treated with interferon preparations.
    Barmak SL; Vilcek J
    Arch Gesamte Virusforsch; 1973; 43(3):273-83. PubMed ID: 4359178
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of high temperature on human cells in culture, their sensitivity to viruses and their interferon-producing capacity.
    Kognovitskaya AI; Bokhonko AI; Mamontova TV; Orlova TG
    Acta Virol; 1987 Jan; 31(1):7-12. PubMed ID: 2437783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular quiescence modulates and replication of L15 mutants of vesicular stomatitis virus.
    Francoeur AM; Stanners CP
    J Gen Virol; 1980 Oct; 50(2):337-44. PubMed ID: 6161988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable interferon productivity of Vero cells. Brief report.
    Kono S; Koase M; Sakata H; Shimizu Y
    Arch Gesamte Virusforsch; 1972; 37(1):141-3. PubMed ID: 4336961
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of interferon in enucleated cells.
    Young CS; Pringle CR; Follett EA
    J Virol; 1975 Feb; 15(2):428-9. PubMed ID: 163365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attempts to demonstrate the interferon defense mechanism in cultured mosquito cells.
    Kascsak RJ; Lyons MJ
    Arch Gesamte Virusforsch; 1974; 45(1-2):149-54. PubMed ID: 4369796
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon production and activity in mouse neuroblastoma cells.
    Stohlman SA; Sakaguchi AY; Hiti A
    Arch Virol; 1978; 57(1):91-6. PubMed ID: 207242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cycloheximide and puromycin on the antiviral and anticellular activities of human interferon.
    Kuwata T; Fuse A; Morinaga N
    J Gen Virol; 1977 Oct; 37(1):195-8. PubMed ID: 199703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.